Dose Escalation Tri...
 
Notifications
Clear all

Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer

1 Posts
1 Users
0 Likes
837 Views
johan
(@j)
Joined: 5 years ago
Posts: 2115
Topic starter  

"AZD1775 in combination with gemcitabine and radiation therapy was well tolerated at a dose that produced target engagement in a surrogate tissue. The overall survival is substantially higher than prior results combining gemcitabine with radiation therapy and warrants additional investigation."

https://ascopubs.org/doi/10.1200/JCO.19.00730


   
Quote
Share: